FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109479865> ?p ?o ?g. }

• W2109479865 endingPage "595" @default.
• W2109479865 startingPage "588" @default.
• W2109479865 abstract "Insulin resistance plays a central role in the development of type 2 diabetes, but the precise defects in insulin action remain to be elucidated. Glycogen synthase kinase 3 (GSK-3) can negatively regulate several aspects of insulin signaling, and elevated levels of GSK-3 have been reported in skeletal muscle from diabetic rodents and humans. A limited amount of information is available regarding the utility of highly selective inhibitors of GSK-3 for the modification of insulin action under conditions of insulin resistance. In the present investigation, we describe novel substituted aminopyrimidine derivatives that inhibit human GSK-3 potently (K(i) < 10 nmol/l) with at least 500-fold selectivity against 20 other protein kinases. These low molecular weight compounds activated glycogen synthase at approximately 100 nmol/l in cultured CHO cells transfected with the insulin receptor and in primary hepatocytes isolated from Sprague-Dawley rats, and at 500 nmol/l in isolated type 1 skeletal muscle of both lean Zucker and ZDF rats. It is interesting that these GSK-3 inhibitors enhanced insulin-stimulated glucose transport in type 1 skeletal muscle from the insulin-resistant ZDF rats but not from insulin-sensitive lean Zucker rats. Single oral or subcutaneous doses of the inhibitors (30-48 mg/kg) rapidly lowered blood glucose levels and improved glucose disposal after oral or intravenous glucose challenges in ZDF rats and db/db mice, without causing hypoglycemia or markedly elevating insulin. Collectively, our results suggest that these selective GSK-3 inhibitors may be useful as acute-acting therapeutics for the treatment of the insulin resistance of type 2 diabetes." @default.
• W2109479865 created "2016-06-24" @default.
• W2109479865 creator A5008226259 @default.
• W2109479865 creator A5022864991 @default.
• W2109479865 creator A5032307779 @default.
• W2109479865 creator A5034834995 @default.
• W2109479865 creator A5035976996 @default.
• W2109479865 creator A5040448552 @default.
• W2109479865 creator A5054071613 @default.
• W2109479865 creator A5064076137 @default.
• W2109479865 creator A5066380283 @default.
• W2109479865 creator A5068529537 @default.
• W2109479865 creator A5070739512 @default.
• W2109479865 creator A5073662178 @default.
• W2109479865 creator A5087021346 @default.
• W2109479865 date "2003-03-01" @default.
• W2109479865 modified "2023-10-11" @default.
• W2109479865 title "Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo" @default.
• W2109479865 cites W1527792826 @default.
• W2109479865 cites W1555947589 @default.
• W2109479865 cites W1570362997 @default.
• W2109479865 cites W1978046076 @default.
• W2109479865 cites W1982958012 @default.
• W2109479865 cites W1986362116 @default.
• W2109479865 cites W1992527405 @default.
• W2109479865 cites W1997937533 @default.
• W2109479865 cites W2001866120 @default.
• W2109479865 cites W2005572521 @default.
• W2109479865 cites W2019612671 @default.
• W2109479865 cites W2019659823 @default.
• W2109479865 cites W2022309233 @default.
• W2109479865 cites W2038063954 @default.
• W2109479865 cites W2038594687 @default.
• W2109479865 cites W2045278002 @default.
• W2109479865 cites W2046766433 @default.
• W2109479865 cites W2047308859 @default.
• W2109479865 cites W2047980471 @default.
• W2109479865 cites W2049761828 @default.
• W2109479865 cites W2049875806 @default.
• W2109479865 cites W2051788298 @default.
• W2109479865 cites W2055753122 @default.
• W2109479865 cites W2058138221 @default.
• W2109479865 cites W2075171810 @default.
• W2109479865 cites W2098017074 @default.
• W2109479865 cites W2098601481 @default.
• W2109479865 cites W2104979495 @default.
• W2109479865 cites W2112820874 @default.
• W2109479865 cites W2124867155 @default.
• W2109479865 cites W2130357785 @default.
• W2109479865 cites W2149189904 @default.
• W2109479865 cites W2161071101 @default.
• W2109479865 cites W2170537843 @default.
• W2109479865 cites W2338614084 @default.
• W2109479865 cites W2341471202 @default.
• W2109479865 cites W4229598164 @default.
• W2109479865 cites W4235921012 @default.
• W2109479865 cites W4241442678 @default.
• W2109479865 cites W4295216797 @default.
• W2109479865 cites W53659813 @default.
• W2109479865 cites W6823376 @default.
• W2109479865 doi "https://doi.org/10.2337/diabetes.52.3.588" @default.
• W2109479865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12606497" @default.
• W2109479865 hasPublicationYear "2003" @default.
• W2109479865 type Work @default.
• W2109479865 sameAs 2109479865 @default.
• W2109479865 citedByCount "429" @default.
• W2109479865 countsByYear W21094798652012 @default.
• W2109479865 countsByYear W21094798652013 @default.
• W2109479865 countsByYear W21094798652014 @default.
• W2109479865 countsByYear W21094798652015 @default.
• W2109479865 countsByYear W21094798652016 @default.
• W2109479865 countsByYear W21094798652017 @default.
• W2109479865 countsByYear W21094798652018 @default.
• W2109479865 countsByYear W21094798652019 @default.
• W2109479865 countsByYear W21094798652020 @default.
• W2109479865 countsByYear W21094798652021 @default.
• W2109479865 countsByYear W21094798652022 @default.
• W2109479865 countsByYear W21094798652023 @default.
• W2109479865 crossrefType "journal-article" @default.
• W2109479865 hasAuthorship W2109479865A5008226259 @default.
• W2109479865 hasAuthorship W2109479865A5022864991 @default.
• W2109479865 hasAuthorship W2109479865A5032307779 @default.
• W2109479865 hasAuthorship W2109479865A5034834995 @default.
• W2109479865 hasAuthorship W2109479865A5035976996 @default.
• W2109479865 hasAuthorship W2109479865A5040448552 @default.
• W2109479865 hasAuthorship W2109479865A5054071613 @default.
• W2109479865 hasAuthorship W2109479865A5064076137 @default.
• W2109479865 hasAuthorship W2109479865A5066380283 @default.
• W2109479865 hasAuthorship W2109479865A5068529537 @default.
• W2109479865 hasAuthorship W2109479865A5070739512 @default.
• W2109479865 hasAuthorship W2109479865A5073662178 @default.
• W2109479865 hasAuthorship W2109479865A5087021346 @default.
• W2109479865 hasBestOaLocation W21094798651 @default.
• W2109479865 hasConcept C112446052 @default.
• W2109479865 hasConcept C126322002 @default.
• W2109479865 hasConcept C134018914 @default.
• W2109479865 hasConcept C150903083 @default.
• W2109479865 hasConcept C182996813 @default.

• next